NCT06868277 · Interventional trial
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Overall registry status Recruiting
Phase 3
Conditions Carcinoma, Non-Small Cell Lung
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory